By proceeding, you agree to our Terms of Use and Privacy Policy.
Chief Executive Officer
#Commercialization #medicines
#NorthAmerica
Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human
Chief Safety Officer
#Physiological #Sciences #Medicines
#Europe
Alison is a pharmacologist with a PhD in biochemistry.
President and CEO
#innovation #clinicalpharmacology #diligence #medicines
Board certified physician scientist with a substantial and diverse clinical experience.
CEO
#healthcare #oncology #medicines
Barry Greene joined Alnylam in 2003 and has more than 25 years of experience in healthcare, pharmaceutical, and biotechnology industries. Prior to Alnylam, Barry was General Manager of Oncology at Mil
Associate Director - Early Access Program Operations
#operations #medicines
#Northamerica
Bethany Bearden is currently workiong as Associate Director - Early Access Program Operations at Blueprint Medicines.
#health #cancer #policy #medicines #healthcareinnovation
Senior executive and passionate public health advocate with 30+ years experience in law, government affairs and policy, public affairs and stakeholder engagement.
Senior Vice President, Global Biologics
#biological #medicines
Fouad Atouf is Vice President, Global Biologics, for USP. He leads all scientific activities related to the development and maintenance of documentary and reference standards for biologics and advance
Head, Global Regulatory, Precision Medicine/Digital Health
#medicines #healthpolicy #medicaldevices
As Head of Precision Medicine & Digital Health Global Regulatory at GSK, I provide creative and tactical solutions to accelerate patient access to life-saving medicines. Most recently I was Global Reg
Executive Director, Regeneron Genetic Medicines
#regeneron #medicines #health
Leah Sabin works as Executive Director, Regeneron Genetic Medicines at Regeneron
Clinical Lead - Medicines Optimisation
#medicines
Mandeep Butt, MRPharmS, is the Director for the Integrating Pharmacy and Medicines Optimisation (IPMO) Programme at North London Partners, with extensive experience in the NHS from frontline clinical
Deputy Director, Clinical Investigations and Trials
#Medicines #Healthcare
Dr Martin O'Kane MRPharmS is Unit Manager of the Clinical Trials Unit in the Licensing Division of the Medicines & Healthcare products Regulatory Agency (MHRA).
Executive Partner
#medicines #operations #researchdevelopment
Paul joined Flagship Pioneering in 2019 as Executive Partner, Flagship Pioneering and President, Pioneering Medicines. In his role at Flagship, Paul works with growth company CEOs and their teams to a